UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 80

Sortiert nach

Fibroblasts Mobilize Tumor Cell Glycogen to Promote Proliferation and Metastasis

Cell metabolism, 2019-01, Vol.29 (1), p.141-155.e9

2019

Volltextzugriff (PDF)

Relationship of Type II Diabetes and Metformin Use to Ovarian Cancer Progression, Survival, and Chemosensitivity

Obstetrics and gynecology (New York. 1953), 2012-01, Vol.119 (1), p.61-67

2012

Volltextzugriff (PDF)

Primary gynecologic lymphoma when diagnosed by a gynecologist: A case series

Gynecologic oncology reports, 2024-06, Vol.53, p.101409, Article 101409

2024

Volltextzugriff (PDF)

Efficacy and safety of bevacizumab in recurrent sex cord‐stromal ovarian tumors: Results of a phase 2 trial of the Gynecologic Oncology Group

Cancer, 2014-02, Vol.120 (3), p.344-351

2014

Volltextzugriff (PDF)

Nanoscale Coordination Polymers Codeliver Chemotherapeutics and siRNAs to Eradicate Tumors of Cisplatin-Resistant Ovarian Cancer

Journal of the American Chemical Society, 2016-05, Vol.138 (18), p.6010-6019

2016

Volltextzugriff (PDF)

Phyllodes tumor of the vulva: A case report and literature review highlighting a novel manifestation of Cowden syndrome

Gynecologic oncology reports, 2021-05, Vol.36, p.100752, Article 100752

2021

Volltextzugriff (PDF)

Identity-related experiences of Asian American trainees in gynecologic oncology

Gynecologic oncology reports, 2022-12, Vol.44, p.101097-101097, Article 101097

2022

Volltextzugriff (PDF)

Multi-level Proteomics Identifies CT45 as a Chemosensitivity Mediator and Immunotherapy Target in Ovarian Cancer

Cell, 2018-09, Vol.175 (1), p.159-170.e16

2018

Volltextzugriff (PDF)

Phase II study of intraperitoneal submicron particle paclitaxel (SPP) plus IV carboplatin and paclitaxel in patients with epithelial ovarian cancersurgery

Gynecologic oncology reports, 2020-11, Vol.34, p.100627-100627, Article 100627

2020

Volltextzugriff (PDF)

Nanomedicine for Combination Therapy of Cancer

EBioMedicine, 2015-05, Vol.2 (5), p.366-367

2015

Volltextzugriff (PDF)

Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via α5-Integrin, which Is a Therapeutic Target

Cancer research (Chicago, Ill.), 2008-04, Vol.68 (7), p.2329-2339

2008

Volltextzugriff (PDF)

Effect of risk-reducing salpingo-oophorectomy on sex steroid hormone serum levels among postmenopausal women: an NRG Oncology/Gynecologic Oncology Group study

American journal of obstetrics and gynecology, 2022-07, Vol.227 (1), p.61.e1-61.e18

2022

Volltextzugriff (PDF)

Superior vena cava syndrome associated with uterine serous carcinoma

Gynecologic oncology reports, 2020-08, Vol.33, p.100593, Article 100593

2020

Volltextzugriff (PDF)

Second primary rhabdomyosarcoma of the uterine cervix presenting with synchronous ovarian Sertoli-Leydig cell tumor: An illustrative case of DICER1 syndrome

Gynecologic oncology reports, 2018-08, Vol.25, p.94-97

2018

Volltextzugriff (PDF)

A National Network to Advance the Field of Cancer and Female Sexuality

Journal of sexual medicine, 2013-02, Vol.10 (2), p.319-325

2013

Volltextzugriff (PDF)

Foreword

Gynecologic oncology, 2022-08, Vol.166, p.S1

2022

Volltextzugriff (PDF)

Relationship of Type II Diabetes and Metformin Use to Ovarian Cancer Progression, Survival, and Chemosensitivity

Obstetrical & gynecological survey, 2012-02, Vol.67 (2), p.96-97

2012

Volltextzugriff (PDF)

Stage IIIC Small Cell Carcinoma of the Ovary: Survival With Conservative Surgery and Chemotherapy

Obstetrics and gynecology (New York. 1953), 2004-05, Vol.103 (5, Part 2 Suppl), p.1120-1123

2004

Volltextzugriff (PDF)

Clues to the origins of ovarian cancer: Family history assessment, genetic screening are key to prevention

Contemporary ob/gyn, 2022-04, Vol.67 (4), p.18

2022

Volltextzugriff (PDF)

Differences in Sociodemographic Disparities in Patients Undergoing Surgery for Advanced Colorectal and Ovarian Cancer

Annals of surgical oncology, 2021-05, Vol.28 (12), p.7795-7806

2021

Volltextzugriff (PDF)

Intent-to-treat analysis of stage Ib and IIa cervical cancer in the United States: radiotherapy or surgery 1988–1995

Obstetrics and gynecology (New York. 1953), 2001-02, Vol.97 (2), p.248-254

2001

Volltextzugriff (PDF)

Effect of Risk-Reducing Salpingo-Oophorectomy on Sex-Steroid Hormone Serum Levels among Post-Menopausal Women: An NRG Oncology/GOG Study

American journal of obstetrics and gynecology, 2022-02, Vol.227 (1), p.61.e1-61.e18

2022

Volltextzugriff (PDF)

Abstract 5899: Compartment-resolved proteomics reveal NNMT as a master metabolic regulator of cancer associated fibroblasts

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.5899-5899

2017

Volltextzugriff (PDF)

Metabolic reprogramming of the stromal epigenome in ovarian cancer metastasis

The FASEB journal, 2019-04, Vol.33 (S1), p.lb240-lb240

2019

Volltextzugriff (PDF)

β3 -Integrin Expression on Tumor Cells Inhibits Tumor Progression, Reduces Metastasis, and Is Associated with a Favorable Prognosis in Patients with Ovarian Cancer

The American journal of pathology, 2009-11, Vol.175 (5), p.2184-2196

2009

Volltextzugriff (PDF)

1 – 25 von 80

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieClinical Cancer Research

ThemaOncology

ThemaOvarian Neoplasms - Pathology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(78)

Publikationsform

Sprache

Englisch
(80)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Fibroblasts Mobilize Tumor Cell Glycogen to Promote Proliferation and Metastasis

Relationship of Type II Diabetes and Metformin Use to Ovarian Cancer Progression, Survival, and Chemosensitivity

Primary gynecologic lymphoma when diagnosed by a gynecologist: A case series

Efficacy and safety of bevacizumab in recurrent sex cord‐stromal ovarian tumors: Results of a phase 2 trial of the Gynecologic Oncology Group

Nanoscale Coordination Polymers Codeliver Chemotherapeutics and siRNAs to Eradicate Tumors of Cisplatin-Resistant Ovarian Cancer

Phyllodes tumor of the vulva: A case report and literature review highlighting a novel manifestation of Cowden syndrome

Identity-related experiences of Asian American trainees in gynecologic oncology

Multi-level Proteomics Identifies CT45 as a Chemosensitivity Mediator and Immunotherapy Target in Ovarian Cancer

Phase II study of intraperitoneal submicron particle paclitaxel (SPP) plus IV carboplatin and paclitaxel in patients with epithelial ovarian cancersurgery

Nanomedicine for Combination Therapy of Cancer

Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via α5-Integrin, which Is a Therapeutic Target

Effect of risk-reducing salpingo-oophorectomy on sex steroid hormone serum levels among postmenopausal women: an NRG Oncology/Gynecologic Oncology Group study

Superior vena cava syndrome associated with uterine serous carcinoma

Second primary rhabdomyosarcoma of the uterine cervix presenting with synchronous ovarian Sertoli-Leydig cell tumor: An illustrative case of DICER1 syndrome

A National Network to Advance the Field of Cancer and Female Sexuality

Foreword

Relationship of Type II Diabetes and Metformin Use to Ovarian Cancer Progression, Survival, and Chemosensitivity

Stage IIIC Small Cell Carcinoma of the Ovary: Survival With Conservative Surgery and Chemotherapy

Clues to the origins of ovarian cancer: Family history assessment, genetic screening are key to prevention

Differences in Sociodemographic Disparities in Patients Undergoing Surgery for Advanced Colorectal and Ovarian Cancer

Intent-to-treat analysis of stage Ib and IIa cervical cancer in the United States: radiotherapy or surgery 1988–1995

Effect of Risk-Reducing Salpingo-Oophorectomy on Sex-Steroid Hormone Serum Levels among Post-Menopausal Women: An NRG Oncology/GOG Study

Abstract 5899: Compartment-resolved proteomics reveal NNMT as a master metabolic regulator of cancer associated fibroblasts

Metabolic reprogramming of the stromal epigenome in ovarian cancer metastasis

β3 -Integrin Expression on Tumor Cells Inhibits Tumor Progression, Reduces Metastasis, and Is Associated with a Favorable Prognosis in Patients with Ovarian Cancer

Aktive Filter

Suchergebnisse filtern